This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.
What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended January 2025.
Dentsply International (XRAY) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Dentsply (XRAY) delivered earnings and revenue surprises of -39.53% and 1.56%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -30.65% and 3.81%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Align Technology (ALGN) Beats Q4 Earnings Estimates
by Zacks Equity Research
Align Technology (ALGN) delivered earnings and revenue surprises of 0.41% and 0.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Sustained Product Demand Drive BDX Stock Before Q1 Earnings?
by Zacks Equity Research
The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory market dynamics.
Reasons to Retain The Cooper Companies Stock in Your Portfolio Now
by Zacks Equity Research
COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.
Top Stock Reports for Amazon.com, Procter & Gamble and Sony
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & Gamble Co. (PG) and Sony Group Corp. (SONY), as well as a micro-cap stock The Monarch Cement Co. (MCEM).
Are Options Traders Betting on a Big Move in Cooper Companies (COO) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cooper Companies (COO) stock based on the movements in the options market lately.
The Cooper Companies (COO) International Revenue in Focus: Trends and Expectations
by Zacks Equity Research
Explore how The Cooper Companies' (COO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls
by Zacks Equity Research
COO's top line fails to meet market expectations despite recording strong growth. However, improvement in operating margin bodes well.
The Cooper Companies (COO) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended October 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The Cooper Companies (COO) Q4 Earnings Beat Estimates
by Zacks Equity Research
The Cooper Companies (COO) delivered earnings and revenue surprises of 4% and 0.89%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Strong Segmental Sales to Drive Cooper Companies Q4 Earnings?
by Zacks Equity Research
COO's fiscal fourth-quarter results are likely to reflect segmental strength.
Unveiling The Cooper Companies (COO) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for The Cooper Companies (COO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2024.
Macro Challenges to Hurt Patterson Companies' Q2 Earnings?
by Zacks Equity Research
PDCO's fiscal second-quarter results are likely to reveal a decline in both the Dental and Animal Health segments, reflecting challenges like moderating traffic to clinics.
Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ocugen (OCGN) delivered earnings and revenue surprises of 0% and 5.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Biote Corp. (BTMD) Beats Q3 Earnings Estimates
by Zacks Equity Research
biote Corp. (BTMD) delivered earnings and revenue surprises of 266.67% and 0%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Add The Cooper Companies Stock to Your Portfolio Now
by Zacks Equity Research
COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.
Becton Dickinson (BDX) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Becton Dickinson (BDX) delivered earnings and revenue surprises of 1.06% and 1.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Should Invesco Bloomberg Pricing Power ETF (POWA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for POWA
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now
by Zacks Equity Research
GKOS continues to benefit from a robust demand for its products and expansion in new markets. A strong development pipeline raises optimism.
Here's Why You Should Add DaVita Stock to Your Portfolio Now
by Zacks Equity Research
DVA's strength in its kidney care business raises optimism about the stock.
Three Reasons Why You Should Hold BDX Stock in Your Portfolio Now
by Zacks Equity Research
BD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns.
Top Stock Reports for McDonald's, Danaher & S&P Global
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corp. (MCD), Danaher Corp. (DHR) and S&P Global Inc. (SPGI), as well as two micro-cap stocks Twin Disc, Inc. (TWIN) and The Cato Corp. (CATO).
Reasons to Add The Cooper Companies Stock to Your Portfolio Now
by Zacks Equity Research
COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.